37
Participants
Start Date
July 31, 2003
Study Completion Date
December 31, 2003
Maraviroc (UK-427,857)
150 mg oral tablet twice daily while fasted on Days 1-9 and on Day 10 (morning dose only)
Maraviroc (UK-427,857)
100 mg oral tablet once daily while fasted on Days 1-10
Maraviroc (UK-427,857)
300 mg oral tablet once daily while fasted on Days 1-10
Maraviroc (UK-427,857)
150 mg oral tablet twice daily with food on Days 1-9 and on Day 10 (morning dose only)
Placebo
Matching placebo oral tablet on Days 1-10 (fed and fasted)
Pfizer Investigational Site, Hamburg
Pfizer Investigational Site, Cologne
Pfizer Investigational Site, Frankfurt
Pfizer Investigational Site, Birmingham
Pfizer Investigational Site, Boston
Pfizer Investigational Site, London
Pfizer Investigational Site, London
Lead Sponsor
Collaborators (1)
Pfizer
INDUSTRY
ViiV Healthcare
INDUSTRY